1 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 801-810.
|
2 |
Shon AS, Bajwa RP, Russo TA. Hypervirulent (hyper-mucoviscous) Klebsiella pneumoniae: a new and dangerous breed[J]. Virulence, 2013, 4 (2): 107-118.
|
3 |
Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis[J]. Virulence, 2014, 5 (1): 4-11.
|
4 |
Sales Júnior JA, David CM, Hatum R, et al. An epidemiological study of sepsis in intensive care units: sepsis Brazil study[J]. Rev Bras Ter Intensiva, 2006, 18 (1): 9-17.
|
5 |
Fleischmann C, Scherag A, Adhikari NK, et al. Asse-ssment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations[J]. Am J Respir Crit Care Med, 2016, 193 (3): 259-272.
|
6 |
Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J]. Crit Care Med, 2006, 34 (6): 1589-1596.
|
7 |
Meatherall BL, Gregson D, Ross T, et al. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia[J]. Am J Med, 2009, 122 (9): 866-873.
|
8 |
Zhang Y, Zeng J, Liu W, et al. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China[J]. J Infect, 2015, 71 (5): 553-560.
|
9 |
Ye M, Tu J, Jiang J, et al. Clinical and genomic analysis of liver abscess-causing Klebsiella pneumoniae identifies new liver abscess-associated virulence genes[J]. Front Cell Infect Microbiol, 2016 (6): 165.
|
10 |
Rossi B, Gasperini M, Leflon-Guibout V, et al. Hyper-virulent Klebsiella pneumoniae in cryptogenic liver abscesses, Paris, France[J]. Emerg Infect Dis, 2018, 24 (2): 221-229.
|
11 |
Zhang Y, Zhao C, Wang Q, et al. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance[J]. Antimicrob Agents Chemother, 2016, 60 (10): 6115-6120.
|
12 |
Paganin F, Lilienthal F, Bourdin A, et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor[J]. Eur Respir J, 2004, 24 (5): 779-785.
|
13 |
Lin YT, Jeng YY, Chen TL, et al. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008[J]. BMC Infect Dis, 2010 (10): 307.
|
14 |
Qu TT, Zhou JC, Jiang Y, et al. Clinical and microbiological characteristics of Klebsiella pneumoniae liver abscess in east China[J]. BMC Infect Dis, 2015 (15): 161.
|
15 |
Shelat VG, Chia CL, Yeo CS, et al. Pyogenic liver abscess: does Escherichia coli cause more adverse outcomes than Klebsiella pneumoniae?[J]. World J Surg, 2015, 39 (10): 2535-2542.
|
16 |
Zhu X, Wang S, Jacob R, et al. A 10-year retrospective analysis of clinical profiles, laboratory characteristics and management of pyogenic liver abscesses in a Chinese hospital[J]. Gut Liver, 2011, 5 (2): 221-227.
|
17 |
Surgers L, Boyd A, Girard PM, et al. ESBL-producing strain of hypervirulent Klebsiella pneumoniae K2, France[J]. Emerg Infect Dis, 2016, 22 (9): 1687-1688.
|